Accuray Incorporated (ARAY) - Total Assets

Latest as of June 2026: $443.68 Million USD

Based on the latest financial reports, Accuray Incorporated (ARAY) holds total assets worth $443.68 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Accuray Incorporated - Total Assets Trend (2002–2026)

This chart illustrates how Accuray Incorporated's total assets have evolved over time, based on quarterly financial data. Also see Accuray Incorporated market capitalisation for the company's overall valuation and market capitalisation.

Accuray Incorporated - Asset Composition Analysis

Current Asset Composition (June 2026)

Accuray Incorporated's total assets of $443.68 Million consist of 64.8% current assets and 35.2% non-current assets. Review Accuray Incorporated total liabilities to assess the company's total debt and financial obligations.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 9.3%
Accounts Receivable $67.41 Million 15.2%
Inventory $147.07 Million 33.2%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $0.00 0.0%
Goodwill $57.91 Million 13.1%

Asset Composition Trend (2002–2026)

This chart illustrates how Accuray Incorporated's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Accuray Incorporated stock price today for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Accuray Incorporated's current assets represent 64.8% of total assets in 2026, an increase from 17.3% in 2002.
  • Cash Position: Cash and equivalents constituted 9.3% of total assets in 2026, down from 17.3% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 0.0% in 2002.
  • Asset Diversification: The largest asset category is inventory at 33.2% of total assets.

Accuray Incorporated Competitors by Total Assets

Key competitors of Accuray Incorporated based on total assets are shown below.

Company Country Total Assets
Medtronic plc
SA:MDTC34
Brazil R$93.03 Billion
Demant A/S
CO:DEMANT
Denmark Dkr39.07 Billion
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
China CN¥16.89 Billion
Jafron Biomedical Co Ltd
SHE:300529
China CN¥5.20 Billion
Sinocare Inc
SHE:300298
China CN¥6.25 Billion
Emvision Medical Devices Ltd
AU:EMV
Australia AU$24.94 Million
Theradiag SA
PA:ALTHE
France €11.55 Million
Biosynex
PA:ALBIO
France €149.44 Million

Accuray Incorporated - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.50 1.65 1.86
Quick Ratio 0.74 0.92 1.19
Cash Ratio 0.00 0.00 0.00
Working Capital $96.37 Million $124.89 Million $162.20 Million

Accuray Incorporated - Advanced Valuation Insights

This section examines the relationship between Accuray Incorporated's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.76
Latest Market Cap to Assets Ratio 0.06
Asset Growth Rate (YoY) -5.6%
Total Assets $443.68 Million
Market Capitalization $28.78 Million USD

Valuation Analysis

Below Book Valuation: The market values Accuray Incorporated's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Accuray Incorporated's assets decreased by 5.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Accuray Incorporated (2002–2026)

The table below shows the annual total assets of Accuray Incorporated from 2002 to 2026.

Year Total Assets Change
2026-06-30 $443.68 Million -5.65%
2025-06-30 $470.24 Million +0.34%
2024-06-30 $468.63 Million -2.21%
2023-06-30 $479.21 Million +1.35%
2022-06-30 $472.85 Million -1.51%
2021-06-30 $480.10 Million -2.21%
2020-06-30 $490.93 Million +12.04%
2019-06-30 $438.18 Million +15.70%
2018-06-30 $378.73 Million -6.82%
2017-06-30 $406.46 Million -13.34%
2016-06-30 $469.03 Million -0.20%
2015-06-30 $469.97 Million -5.09%
2014-06-30 $495.19 Million +4.05%
2013-06-30 $475.93 Million +0.58%
2012-06-30 $473.17 Million +3.81%
2011-06-30 $455.78 Million +73.18%
2010-06-30 $263.18 Million -4.08%
2009-06-30 $274.39 Million -6.99%
2008-06-30 $295.00 Million -11.17%
2007-06-30 $332.11 Million +139.58%
2006-06-30 $138.62 Million +59.59%
2005-06-30 $86.86 Million +168.53%
2003-06-30 $32.35 Million +171.25%
2002-06-30 $11.93 Million --

About Accuray Incorporated

NASDAQ:ARAY USA Medical Devices
Market Cap
$28.78 Million
Market Cap Rank
#24018 Global
#5183 in USA
Share Price
$0.24
Change (1 day)
+4.78%
52-Week Range
$0.23 - $1.85
All Time High
$7.46
About

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more